Ulrika Wall

640 total citations
24 papers, 413 citations indexed

About

Ulrika Wall is a scholar working on Cardiology and Cardiovascular Medicine, Hematology and Internal Medicine. According to data from OpenAlex, Ulrika Wall has authored 24 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 8 papers in Hematology and 6 papers in Internal Medicine. Recurrent topics in Ulrika Wall's work include Blood Coagulation and Thrombosis Mechanisms (8 papers), Protease and Inhibitor Mechanisms (6 papers) and Venous Thromboembolism Diagnosis and Management (6 papers). Ulrika Wall is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (8 papers), Protease and Inhibitor Mechanisms (6 papers) and Venous Thromboembolism Diagnosis and Management (6 papers). Ulrika Wall collaborates with scholars based in Sweden, United Kingdom and United States. Ulrika Wall's co-authors include Sverker Jern, Christina Jern, Per Ladenvall, Ulf G. Eriksson, Troy C. Sarich, Lilian Tengborn, Þórdís Jóna Hrafnkelsdóttir, Þórarinn Guðnason, Renli Teng and Susanne Johansson and has published in prestigious journals such as Blood, Hypertension and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Ulrika Wall

24 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ulrika Wall Sweden 13 154 126 89 76 72 24 413
Qianxing Zhou China 10 142 0.9× 154 1.2× 52 0.6× 86 1.1× 52 0.7× 17 440
Foo Leong Li‐Saw‐Hee United Kingdom 11 401 2.6× 72 0.6× 88 1.0× 57 0.8× 130 1.8× 13 601
Antonio Moscardó Spain 14 198 1.3× 133 1.1× 33 0.4× 99 1.3× 70 1.0× 34 688
Ikuo Misumi Japan 7 238 1.5× 50 0.4× 56 0.6× 110 1.4× 24 0.3× 26 445
Yoshinori Takajo Japan 9 191 1.2× 63 0.5× 22 0.2× 85 1.1× 49 0.7× 11 444
Tomoya Hara Japan 9 176 1.1× 100 0.8× 24 0.3× 68 0.9× 60 0.8× 21 364
J Kaliman Austria 13 213 1.4× 42 0.3× 37 0.4× 115 1.5× 39 0.5× 78 513
Birgit Svensson Norway 14 169 1.1× 191 1.5× 50 0.6× 203 2.7× 78 1.1× 29 623
Tomohiro Sakamoto Japan 10 170 1.1× 34 0.3× 32 0.4× 87 1.1× 39 0.5× 11 370
S K Yao United States 11 420 2.7× 153 1.2× 29 0.3× 207 2.7× 117 1.6× 13 686

Countries citing papers authored by Ulrika Wall

Since Specialization
Citations

This map shows the geographic impact of Ulrika Wall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrika Wall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrika Wall more than expected).

Fields of papers citing papers by Ulrika Wall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrika Wall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrika Wall. The network helps show where Ulrika Wall may publish in the future.

Co-authorship network of co-authors of Ulrika Wall

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrika Wall. A scholar is included among the top collaborators of Ulrika Wall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrika Wall. Ulrika Wall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wall, Ulrika, et al.. (2009). Management of major bleedings during anticoagulant treatment with the oral direct thrombin inhibitor ximelagatran or warfarin. Blood Coagulation & Fibrinolysis. 20(8). 667–674. 5 indexed citations
2.
Sarich, Troy C., et al.. (2007). Pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor ximelagatran co-administered with different classes of antibiotics in healthy volunteers. European Journal of Clinical Pharmacology. 63(6). 571–581. 9 indexed citations
3.
Wåhlander, Karin, Henry Eriksson, Torbjörn Lundström, et al.. (2006). Risk of recurrent venous thromboembolism or bleeding in relation to thrombophilic risk factors in patients receiving ximelagatran or placebo for long‐term secondary prevention of venous thromboembolism. British Journal of Haematology. 133(1). 68–77. 13 indexed citations
4.
Eriksson, Ulf G., Johan Karlsson, Holger Fritsch, et al.. (2006). INFLUENCE OF ERYTHROMYCIN ON THE PHARMACOKINETICS OF XIMELAGATRAN MAY INVOLVE INHIBITION OF P-GLYCOPROTEIN-MEDIATED EXCRETION. Drug Metabolism and Disposition. 34(5). 775–782. 25 indexed citations
5.
Wall, Ulrika, et al.. (2005). No Influence of Food on the Pharmacokinetics, Pharmacodynamics or Tolerability of the 24mg and 36mg Oral Tablet Formulations of Ximelagatran. Clinical Drug Investigation. 25(7). 425–433. 2 indexed citations
6.
Sarich, Troy C., et al.. (2005). The pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor ximelagatran when administered with azithromycin and cefuroxime. Clinical Pharmacology & Therapeutics. 77(2). P83–P83. 2 indexed citations
7.
Hrafnkelsdóttir, Þórdís Jóna, Þórarinn Guðnason, Ulrika Wall, Christina Jern, & Sverker Jern. (2004). Regulation of local availability of active tissue‐type plasminogen activator in vivo in man. Journal of Thrombosis and Haemostasis. 2(11). 1960–1968. 41 indexed citations
8.
Sarich, Troy C., et al.. (2004). The Pharmacokinetics and Pharmacodynamics of Ximelagatran, an Oral Direct Thrombin Inhibitor, Are Unaffected by a Single Dose of Alcohol. The Journal of Clinical Pharmacology. 44(4). 388–393. 24 indexed citations
9.
Sarich, Troy C., et al.. (2004). No Pharmacokinetic or Pharmacodynamic Interaction Between Digoxin and the Oral Direct Thrombin Inhibitor Ximelagatran in Healthy Volunteers. The Journal of Clinical Pharmacology. 44(8). 935–941. 17 indexed citations
10.
Sarich, Troy C., et al.. (2004). No Pharmacokinetic or Pharmacodynamic Interaction Between Atorvastatin and the Oral Direct Thrombin Inhibitor Ximelagatran. The Journal of Clinical Pharmacology. 44(8). 928–934. 18 indexed citations
11.
Wall, Ulrika, et al.. (2004). Bioequivalence of ximelagatran, an oral direct thrombin inhibitor, as whole or crushed tablets or dissolved formulation. Current Medical Research and Opinion. 20(3). 325–331. 12 indexed citations
12.
Hrafnkelsdóttir, Þórdís Jóna, Ulrika Wall, Karl Swedberg, Sverker Jern, & Þórarinn Guðnason. (2003). Fibrinolytic capacity increases with age in healthy humans, while endothelium-dependent vasodilation is unaffected. Thrombosis and Haemostasis. 89(2). 374–382. 6 indexed citations
13.
Jern, Christina, Per Ladenvall, Ulrika Wall, & Sverker Jern. (1999). Gene Polymorphism of t-PA is Associated With Forearm Vascular Release Rate of t-PA. Arteriosclerosis Thrombosis and Vascular Biology. 19(2). 454–459. 56 indexed citations
14.
Wall, Ulrika, Sverker Jern, Lilian Tengborn, & Christina Jern. (1998). Evidence of a Local Mechanism for Desmopressin-Induced Tissue-Type Plasminogen Activator Release in Human Forearm. Blood. 91(2). 529–537. 2 indexed citations
15.
Wall, Ulrika, Sverker Jern, Lilian Tengborn, & Christina Jern. (1998). Evidence of a Local Mechanism for Desmopressin-Induced Tissue-Type Plasminogen Activator Release in Human Forearm. Blood. 91(2). 529–537. 38 indexed citations
16.
Wall, Ulrika, Christina Jern, & Sverker Jern. (1997). High capacity for tissue-type plasminogen activator release from vascular endothelium in vivo. Journal of Hypertension. 15(12). 1641–1647. 12 indexed citations
17.
Wall, Ulrika. (1997). In vivo studies on local release of tissue-type plasminogen activator from vascular endothelium. Gothenburg University Publications Electronic Archive (Gothenburg University). 2 indexed citations
18.
Wall, Ulrika, et al.. (1996). Impaired Glucose Tolerance at Five-year Follow-up of Young Men with Borderline Hypertension. Blood Pressure. 5(3). 139–147. 1 indexed citations
19.
Jern, Sverker, et al.. (1995). Long-term stability of blood pressure and pressor reactivity to mental stress in borderline hypertension. American Journal of Hypertension. 8(1). 20–28. 14 indexed citations
20.
Wall, Ulrika, et al.. (1995). Enhanced Levels of Tissue-Type Plasminogen Activator in Borderline Hypertension. Hypertension. 26(5). 796–800. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qianxing Zhou Breakdown of academic impact, for papers by Foo Leong Li‐Saw‐Hee Breakdown of academic impact, for papers by Antonio Moscardó Breakdown of academic impact, for papers by Ikuo Misumi Breakdown of academic impact, for papers by Yoshinori Takajo Breakdown of academic impact, for papers by Tomoya Hara Breakdown of academic impact, for papers by J Kaliman Breakdown of academic impact, for papers by Birgit Svensson Breakdown of academic impact, for papers by Tomohiro Sakamoto Breakdown of academic impact, for papers by S K Yao
Rankless by CCL
2026